Bioray Biotech Co., Ltd (TPEX:7561)
Taiwan · Delayed Price · Currency is TWD 20.10
-0.80 (-3.83%)
Jan 8, 2026, 11:34 AM CST
Bioray Biotech Market Cap
Bioray Biotech has a market cap or net worth of 594.66 million as of January 8, 2026. Its market cap has decreased by -3.94% in one year.
Market Cap
594.66M
Enterprise Value
491.11M
Revenue
230.06M
Ranking
n/a
PE Ratio
19.53
Stock Price
20.10
Market Cap Chart
Since July 6, 2020, Bioray Biotech's market cap has decreased from 1.94B to 594.66M, a decrease of -69.36%. That is a compound annual growth rate of -19.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 8, 2026 | 594.66M | -3.83% |
| Dec 31, 2025 | 618.33M | -2.69% |
| Dec 31, 2024 | 635.45M | -31.65% |
| Dec 29, 2023 | 929.63M | 3.17% |
| Dec 30, 2022 | 901.05M | -30.18% |
| Dec 30, 2021 | 1.29B | 56.23% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 6, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 237.92B |
| PharmaEssentia | 184.92B |
| Lotus Pharmaceutical | 71.53B |
| Heron Neutron Medical | 61.27B |
| Bora Pharmaceuticals Co., LTD. | 59.28B |
| Lin BioScience | 32.14B |
| Lumosa Therapeutics | 31.25B |
| Center Laboratories | 29.97B |